학술논문

A phase IB trial of the oral MEK inhibitor trametinib (GSK1120212) in combination with everolimus in patients with advanced solid tumors
Document Type
Article
Source
In Annals of Oncology January 2015 26(1):58-64
Subject
Language
ISSN
0923-7534